A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,356,100 shares of VIR stock, worth $12.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,356,100
Previous 1,294,600 4.75%
Holding current value
$12.1 Million
Previous $13 Million 5.47%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$8.6 - $11.9 $528,900 - $731,850
61,500 Added 4.75%
1,356,100 $13.7 Million
Q4 2023

Feb 13, 2024

SELL
$7.76 - $10.29 $464,048 - $615,342
-59,800 Reduced 4.42%
1,294,600 $13 Million
Q3 2023

Nov 14, 2023

BUY
$9.14 - $24.62 $1.7 Million - $4.59 Million
186,300 Added 15.95%
1,354,400 $12.7 Million
Q2 2023

Aug 11, 2023

BUY
$23.2 - $27.29 $176,320 - $207,404
7,600 Added 0.65%
1,168,100 $28.7 Million
Q1 2023

May 12, 2023

BUY
$22.26 - $30.85 $2.27 Million - $3.15 Million
102,100 Added 9.65%
1,160,500 $27 Million
Q4 2022

Feb 13, 2023

SELL
$19.96 - $28.22 $9.06 Million - $12.8 Million
-454,094 Reduced 30.02%
1,058,400 $26.8 Million
Q3 2022

Nov 14, 2022

BUY
$18.26 - $31.1 $17.3 Million - $29.5 Million
950,094 Added 168.94%
1,512,494 $29.2 Million
Q2 2022

Aug 12, 2022

BUY
$19.08 - $26.7 $8.93 Million - $12.5 Million
468,000 Added 495.76%
562,400 $14.3 Million
Q1 2022

May 13, 2022

BUY
$21.19 - $40.01 $773,435 - $1.46 Million
36,500 Added 63.04%
94,400 $2.43 Million
Q4 2021

Feb 11, 2022

BUY
$30.97 - $54.03 $1.79 Million - $3.13 Million
57,900 New
57,900 $2.42 Million
Q3 2021

Nov 12, 2021

SELL
$34.9 - $54.54 $2.8 Million - $4.37 Million
-80,102 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$38.75 - $51.0 $3.1 Million - $4.09 Million
80,102 New
80,102 $3.79 Million
Q2 2020

Aug 13, 2020

SELL
$27.89 - $47.86 $1.63 Million - $2.8 Million
-58,500 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$12.04 - $60.2 $704,340 - $3.52 Million
58,500 New
58,500 $2.01 Million

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.18B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.